https://scholars.lib.ntu.edu.tw/handle/123456789/517176
標題: | Reply to X. Yang et al. | 作者: | CHIA-HSUIN CHANG Lin J.-W. Lai M.-S. |
公開日期: | 2011 | 卷: | 29 | 期: | 33 | 起(迄)頁: | 4466 | 來源出版物: | Journal of Clinical Oncology | URI: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-81755171092&doi=10.1200%2fJCO.2011.38.2242&partnerID=40&md5=1a486e92baa78961ace52a84ad71ce80 https://scholars.lib.ntu.edu.tw/handle/123456789/517176 |
ISSN: | 0732-183X | DOI: | 10.1200/JCO.2011.38.2242 | SDG/關鍵字: | angiotensin receptor antagonist; antihypertensive agent; beta adrenergic receptor blocking agent; calcium channel blocking agent; candesartan; dipeptidyl carboxypeptidase inhibitor; hemoglobin A1c; losartan; telmisartan; thiazide diuretic agent; body mass; cancer risk; diabetes mellitus; diabetic nephropathy; diabetic patient; disease duration; Dressler syndrome; drug safety; heart failure; human; letter; priority journal |
顯示於: | 醫學系 |
在 IR 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。